Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series
- PMID: 32293518
- PMCID: PMC7156900
- DOI: 10.1186/s13054-020-2840-8
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series
Conflict of interest statement
None.
Comment on
-
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.JAMA. 2020 Apr 7;323(13):1245-1246. doi: 10.1001/jama.2020.2342. JAMA. 2020. PMID: 32074258 No abstract available.
References
-
- Jiang C, Yang F, Zou H, et al. Chinese expert consensus on supportive treatment of extracorporeal membrane oxygenation novel coronavirus pneumonia. Chin J Emerg Med. 2020;29(00):E009. doi: 10.3760/cma.j.issn.1671-0282.2020.0009. - DOI
-
- MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA Published online February 19, 2020. doi:10.1001/jama.2020.2342. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
